gaby alamilla
@gabysssnc28
Followers
21
Following
36
Statuses
26
Joined March 2022
RT @JTrentMDPhD: @HannahRAbrams presenting on mitigation of drug waste with trabectedin #CTOS2024 #sarcoma. Vial size and rounding matters!…
0
4
0
RT @sarresurgeon: 🏅Estándares de tratamiento en #sarcoma retroperitoneal: 🔸Biopsia preoperatoria 🔬 🔸Referencia a centros de excelencia 🏥 🔸D…
0
7
0
RT @ctosociety: With >1000 participants and >500 abstracts presented - #CTOS2024 is the biggest platform connecting anyone interested in sa…
0
19
0
RT @alegronchi: @tarpswg semiannual meeting at @ctosociety annual meeting in San Diego! A full house and a packed agenda to stimulate advan…
0
17
0
@DorianGarciaMD, participated as a session moderator at the Annual CTOS Meeting, fostering discussions on advancing sarcoma care. #CTOS2024 @incanMX @docenciaincan @sarcoma_mx #SarcomaCare #MedicalLeadership
0
2
10
RT @incanMX: ¿Estás interesada (o) en realizar una rotación en el Instituto Nacional de Cancerología? En abril iniciamos con nuestro period…
0
24
0
RT @DorianGarciaMD: @FioreDoc Indeed, the results are specific to WD-LPS RTP, but we shouldn’t generalize yet. Adding more variables to the…
0
1
0
0
0
1
RT @hydwilliams: We did it. 💪🏼 #ESMOSarcomas2024
@docenciaincan @DorianGarciaMD @SMEOMX @SelnetH2020 @myESMO @gabysssnc28
0
6
0
RT @sarcoma_mx: ⏰HOY 8pm CDMX: #Sarcoma #retroperitoneal irresecable: cuál es el límite? Biología tumoral 🧬 vs habilidad quirúrgica 🤲🏻 Dr.…
0
2
0
RT @sarcoma_mx: #Sarcoma #retroperitoneal metastásico: cuáles son sus principios de tratamiento? ☢️💊🔪 La Dra. Gabriela Alamilla, oncóloga m…
0
2
0
RT @sarcoma_mx: 🔹No se pierdan el 5º y último #webinar de #sarcoma #retroperitoneal: enfermedad recurrente, metastásica o irresecable 🔸Pane…
0
6
0
RT @FAndreMD: Metastatic cancers should be classified as much as possible based on their biology, and agnostic of organ of origin To reach…
0
70
0
RT @sarcoma_mx: No se pierdan el 4º #webinar de #sarcoma #retroperitoneal: 🏥🔪 Cirugía adecuada en centos adecuados 🗓️ Jue 25 ene, 8 pm CDMX…
0
9
0
0
6
0